The Economic Impact of Patent Law in Pharmaceutical Industry: Issue, Challenges and Benefits

Authors

  • Dr. Sushma Singh Associate Professor, Sharda University, Greater Noida, Uttar Pradesh, India Author
  • Neetu Jain Ph.D. Scholar, Sharda University, Greater Noida, Uttar Pradesh, India Author

Downloads

Keywords:

IP Policy, IPRs, Patient Access, Pharmaceutical Industry, incentives

Abstract

The pharmaceutical industry occupies an unusually prominent position in discussions of IP policy and has been at the center of both domestic and international disputes over the interplay between IPRs, R&D incentives, price, and patient access. Despite the fervour of debate surrounding some key issues, there is comparatively little actual data to guide policy-making. This article reviews the empirical literature on intellectual property and pharmaceuticals, analyses methodological issues and important data sources, and outlines some of the most important research questions and knowledge gaps.

Readership Data

🌐

Refreshing Cached Analytics Data

The cached analytics data has become stale and journal.thelawbrigade.com is making a fresh request to fetch the latest data from Google Analytics. This may take 20-30 seconds depending on the server response time from Google Analytics. Please do not close the browser during this time. We appreciate your patience.

Published

09-02-2023

License

Copyright © 2026 by Dr. Sushma Singh, Neetu Jain

The copyright and license terms mentioned on this page take precedence over any other license terms mentioned on the article full text PDF or any other material associated with the article.

How to Cite

Singh, Dr. Sushma, and Neetu Jain. “The Economic Impact of Patent Law in Pharmaceutical Industry: Issue, Challenges and Benefits”. Asia Pacific Law & Policy Review, vol. 9, Feb. 2023, pp. 93-125, https://journal.thelawbrigade.com/aplpr/article/view/268.

Similar Articles

1-10 of 51

You may also start an advanced similarity search for this article.